膜氧化脂与人类大动脉膜狭窄症的严重程度相关
Craig Resch1, Aleksandra Stamenkovic1, Arun Surendran2
1Cardiovascular Lipidomics Laboratory, St. Boniface Hospital, Albrechtsen Research Centre, Manitoba, Canada; Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Manitoba, Canada.
Free radical biology & medicine
|August 1, 2025
概括
氧化脂 (OxPL) 早期积聚在性大动脉狭窄症 (CAVS) 组织中,从轻度到中度阶段显著增加. 这表明,OxPL降低疗法可能有利于早期干预CAVS进展.
科学领域:
- 心血管生物学 心血管生物学
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 石性大动脉狭窄症 (CAVS) 是一种退行性疾病,涉及大动脉的化和缩小,由炎症驱动.
- 氧化脂 (OxPL) 与CAVS有关,但它们在大动脉组织中的特定存在和水平尚不清楚.
研究的目的:
- 开发和应用一种敏感的LC/MS/MS方法,用于识别和量化CAVS患者血和大动脉组织中的OxPL物种.
- 为了确定OxPL水平与CAVS疾病严重程度的关联.
主要方法:
- 使用基于2,4-丁基 (DNPH) 的LC/MS/MS方法.
- 分析了来自70名严重CAVS患者和20名健康捐赠者的大动脉组织.
- 在五个脂类别中量化了60个OxPL物种.
主要成果:
- 确定了32种不同的OxPL物种,其中氧化脂胆 (OxPC) 是最丰富的.
- 随着CAVS严重程度的提高,OxPL水平显著增加,特别是在轻度和中度阶段之间.
- 与健康的门相比,OxPC水平显著上升,123%的中度和239%的严重CAVS.
结论:
- 在大动脉组织中积聚oxPL是CAVS进展的早期事件.
- 这些发现支持使用OxPL降低疗法早期干预的潜在有效性,以管理CAVS.
相关概念视频
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Coronary Artery Disease II: Pathophysiology
36
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
36
Aortic Regurgitation I: Introduction
37
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
37
Mitral Stenosis I: Introduction
36
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
36
Mitral Stenosis IV: Nursing Management
47
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
47
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37


